SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Blondon, A. Hylckama Vlieg, K. L. Wiggins, L. B. Harrington, B. McKnight, K. M. Rice, F. R. Rosendaal, S. R. Heckbert, B. M. Psaty, N. L. Smith, Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers, Journal of Thrombosis and Haemostasis, 2014, 12, 6
  2. 2
    Øjvind Lidegaard, Hormonal contraception, thrombosis and age, Expert Opinion on Drug Safety, 2014, 13, 10, 1353

    CrossRef

  3. 3
    Lourdes Ibáñez, Ken K. Ong, Abel López-Bermejo, David B. Dunger, Francis de Zegher, Hyperinsulinaemic androgen excess in adolescent girls, Nature Reviews Endocrinology, 2014, 10, 8, 499

    CrossRef

  4. 4
    H. Gronier-Gouvernel, G. Robin, Risques cardiovasculaires de la contraception orale estro-progestative : au-delà de la polémique…, Gynécologie Obstétrique & Fertilité, 2014, 42, 3, 174

    CrossRef

  5. 5
    Suzanne M. Bleker, Michiel Coppens, Saskia Middeldorp, Sex, thrombosis and inherited thrombophilia, Blood Reviews, 2014, 28, 3, 123

    CrossRef

  6. 6
    M. Raps, J. Curvers, F.M. Helmerhorst, B.E.P.B. Ballieux, J. Rosing, S. Thomassen, F.R. Rosendaal, H.A.A.M. van Vliet, Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives, Thrombosis Research, 2014, 133, 4, 640

    CrossRef

  7. 7
    H. Lévesque, T. Hanslik, Contraception œstroprogestative et risque thrombotique : des faits cliniques aux conséquences médiatiques, La Revue de Médecine Interne, 2013, 34, 8, 453

    CrossRef

  8. 8
    Genevieve Plu-Bureau, Lorraine Maitrot-Mantelet, Justine Hugon-Rodin, Marianne Canonico, Hormonal contraceptives and venous thromboembolism: An epidemiological update, Best Practice & Research Clinical Endocrinology & Metabolism, 2013, 27, 1, 25

    CrossRef

  9. 9
    M. Raps, F. Rosendaal, B. Ballieux, J. Rosing, S. Thomassen, F. Helmerhorst, H. Vliet, Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial, Journal of Thrombosis and Haemostasis, 2013, 11, 5
  10. 10
    C. KLUFT, S. O. SKOUBY, J. JESPERSEN, J. BURGGRAAF, Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal, Journal of Thrombosis and Haemostasis, 2013, 11, 2
  11. 11
    M. RAPS, F. M. HELMERHORST, K. FLEISCHER, V. A. VAN HYLCKAMA, B. H. STEGEMAN, S. THOMASSEN, F. R. ROSENDAAL, J. ROSING, B. E. P. B. BALLIEUX, H. A. A. M. VAN VLIET, Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: reply to a rebuttal, Journal of Thrombosis and Haemostasis, 2013, 11, 2
  12. 12
    Nathalie Chabbert-Buffet, Jean-Jacques Amy, The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified?, The European Journal of Contraception and Reproductive Health Care, 2013, 18, 2, 75

    CrossRef

  13. 13
    M. Raps, F. M. Helmerhorst, K. Fleischer, A. E. A. Dahm, F. R. Rosendaal, J. Rosing, P. Reitsma, P. M. Sandset, H. A. A. M. van Vliet, The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI, Thrombosis and Haemostasis, 2013, 109, 4, 606

    CrossRef

  14. 14
    N. Chabbert-Buffet, B. Guigues, N. Trillot, C. Biron, P. Morange, G. Pernod, M. Scheffler, S. Brugere, B. Hedon, Thrombose et contraception estroprogestative : mise au point du groupe de travail pluridisciplinaire CNGOF-FNCGM-GEHT-SFMV, La Revue Sage-Femme, 2013, 12, 5, 220

    CrossRef

  15. 15
    N. Chabbert-Buffet, B. Guigues, N. Trillot, C. Biron, P. Morange, G. Pernod, M. Scheffler, S. Brugere, B. Hedon, Thrombose et contraception estroprogestative : mise au point du groupe de travail pluridisciplinaire CNGOF-FNCGM-GEHT-SFMV, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2013, 42, 4, 309

    CrossRef

  16. 16
    Suman Sood, Barbara A Konkle, Consultative Hemostasis and Thrombosis, 2013,

    CrossRef

  17. 17
    ØJVIND LIDEGAARD, IAN MILSOM, REYNIR TOMAS GEIRSSON, FINN EGIL SKJELDESTAD, Hormonal contraception and venous thromboembolism, Acta Obstetricia et Gynecologica Scandinavica, 2012, 91, 7
  18. 18
    B.H. STEGEMAN, F. M. HELMERHORST, H. L. VOS, F. R. ROSENDAAL, A. VAN HYLCKAMA VLIEG, Sex hormone-binding globulin levels are not causally related to venous thrombosis risk in women not using hormonal contraceptives, Journal of Thrombosis and Haemostasis, 2012, 10, 10